Laird Norton Wetherby Wealth Management’s Abiomed Inc ABMD Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-747	Closed	-$247K	–	996
2022 Q1	$247K	Sell	747 -76	-9%	-$23.4K	0.01%	781
2021 Q4	$296K	Buy	823 +18	+2%	+$6.08K	0.02%	721
2021 Q3	$262K	Buy	805 +9	+1%	+$3.05K	0.02%	768
2021 Q2	$248K	Sell	796 -22	-3%	-$6.75K	0.02%	784
2021 Q1	$261K	Buy	818 +12	+1%	+$3.84K	0.02%	663
2020 Q4	$261K	Sell	806 -37	-4%	-$10.2K	0.02%	720
2020 Q3	$234K	Sell	843 -1	-0.1%	-$288	0.02%	603
2020 Q2	$204K	Buy	+844	New	+$169K	0.02%	642

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's ABMD Position: Q2 2022 in Review

Laird Norton Wetherby Wealth Management sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 747 shares — an estimated $247K sold.

Laird Norton Wetherby Wealth Management first reported a position in ABMD in Q2 2020 and held it in 8 quarters. The position peaked at $296K in Q4 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

Laird Norton Wetherby Wealth Management reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
Laird Norton Wetherby Wealth Management sold 747 Abiomed Inc shares in Q2 2022, an estimated $247K.
Laird Norton Wetherby Wealth Management first reported a position in Abiomed Inc in Q2 2020 and held it in 8 quarters.
Laird Norton Wetherby Wealth Management's Abiomed Inc position peaked at $296K in Q4 2021.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2022, filed 15 Aug 2022.